Lovastatin stimulates human vascular smooth muscle cell expression of bone morphogenetic protein-2, a potent inhibitor of low-density lipoprotein-stimulated cell growth

Biochemical and Biophysical Research Communications

Volumn 302, Issue 1, 2003, Pages 67-72

  Emmanuele, Luca ^a   Ortmann, Jana ^a   Doerflinger, Tim ^a   Traupe, Tobias ^a   Barton, Matthias ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

BMP statins; Bone; Cholesterol; HMG CoA reductase inhibitor; Low density lipoprotein; Plaque rupture; Reverse transcriptase polymerase chain reaction; Risk factors; Thymidine incorporation; Transforming growth factor

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; MEVINOLIN; OSTEOGENIC PROTEIN 1; RECOMBINANT PROTEIN;

ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; GENETIC CODE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; OSSIFICATION; PLAQUE FORMING CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0037470354     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00109-8     Document Type: Article

References (29)

1. Ross R. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340:1999;115-126.
2. Libby P. What have we learned about the biology of atherosclerosis? The role of inflammation. Am. J. Cardiol. 88:2001;3J-6J.
3. Falk E. Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br. Heart J. 50:1983;127-134.
4. Libby P., Aikawa M. Stabilization of atherosclerotic plaques: new mechanisms and clinical targets. Nat. Med. 8:2002;1257-1262.
5. Jeziorska M., McCollum C., Wooley D.E. Observations on bone formation and remodelling in advanced atherosclerotic lesions of human carotid arteries. Virchows Arch. 433:1998;559-565.
6. Bostrom K., Watson K.E., Horn S., Wortham C., Herman I.M., Demer L.L. Bone morphogenetic protein expression in human atherosclerotic lesions. J. Clin. Invest. 91:1993;1800-1809.
7. Stary H.C. The development of calcium deposits in atherosclerotic lesions and their persistence after lipid regression. Am. J. Cardiol. 88:2001;16E-19E.
8. Haudenschild C.C. Pathogenesis of atherosclerosis: state of the art. Cardiovasc. Drugs Ther. (Suppl. 5):1990;993-1004.
9. Kato M., Patel M.S., Levasseur R., Lobov I., Chang B.H.J., Glass D.A., Hartmann C., Li L., Brayton C.F., Lang R.A., Karsenty G., Chan L. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistant embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J. Cell Biol. 157:2002;303-314.
10. Gong Y., Slee R.B., Fukai N., Rawadi G., Roman-Roman S., Reginato A.M., Wang H., Cundy T., Glorieux F.H., Lev D., Zacharin M., Oexle K., Marcelino J., Suwairi W., Heeger S., Sabatakos G., Apte S., Adkins W.N., Allgrove J., Arslan-Kirchner M., Batch J.A., Beighton P., Black G.C., Boles R.G., Boon L.M., Borrone C., Brunner H.G., Carle G.F., Dallapiccola B., De Paepe A., Floege B., Halfhide M.L., Hall B., Hennekam R.C., Hirose T., Jans A., Juppner H., Kim C.A., Keppler-Noreuil K., Kohlschuetter A., LaCombe D., Lambert M., Lemyre E., Letteboer T., Peltonen L., Ramesar R.S., Romanengo M., Somer H., Steichen-Gersdorf E., Steinmann B., Sullivan B., Superti-Furga A., Swoboda W., van den Boogaard M.J., Van Hul W., Vikkula M., Votruba M., Zabel B., Garcia T., Baron R., Olsen B.R., Warman M.L. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell. 107:2001;513-523.
11. Urist M.R. Bone: formation by autoinduction. Science. 150:1965;893-899.
12. Miyazono K., Kusanagi K., Inoue H. Divergence and convergence of TGF-β/BMP signaling. J. Cell Physiol. 187:2001;265-276.
13. Délot E.C., Bahamonde M.E., Zhao M., Lyons K.M. BMP signaling is required for septation of the outflow tract of the mammalian heart. Development. 130:2003;209-220.
14. Willette R.N., Gu J.L., Lysko P.G., Anderson K.M., Minehart H., Yue T. BMP-2 gene expression and effects on human vascular smooth muscle cells. J. Vasc. Res. 36:1999;120-125.
15. Dhore C.R., Cleutjens J.P., Lutgens E., Cleutjens K.B., Geusens P.P., Kitslaar P.J., Tordoir J.H., Spronk H.M., Vermeer C., Daemen M.J. Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler. Thromb. Vasc. Biol. 21:2001;1998-2003.
16. Dorai H., Vukicevic S., Sampath T.K. Bone morphogenetic protein-7 (osteogenic protein-1) inhibits smooth muscle cell proliferation and stimulates the expression of markers that are characteristic of SMC phenotype in vitro. J. Cell Physiol. 184:2000;37-45.
17. Nakaoka T., Gonda K., Ogita T., Otawara-Hamamoto Y., Okabe F., Kira Y., Harii K., Miyazono K., Takuwa Y., Fujita T. Inhibition of rat vascular smooth muscle proliferation in vitro and in vivo by bone morphogenetic protein-2. J. Clin. Invest. 100:1997;2824-2832.
18. Corti R., Fayad Z.A., Fuster V., Worthley S.G., Helft G., Chesebro J., Mercuri M., Badimon J.J. Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation. 104:2001;249-252.
19. Shiomi M., Ito T., Hirouchi Y., Enomoto M. Fibromuscular cap composition is important for the stability of established atherosclerotic plaques in mature WHHL rabbits treated with statins. Atherosclerosis. 157:2001;75-84.
20. Mundy G., Garrett R., Harris S., Chan J., Chen D., Rossini G., Boyce B., Zhao M., Gutierrez G. Stimulation of bone formation in vitro and in rodents by statins. Science. 286:1999;1946-1949.
21. Phillips B.W., Belmonte N., Vernochet C., Ailhaud G., Dani C. Compactin enhances osteogenesis in murine embryonic stem cells. Biochem. Biophys. Res. Commun. 284:2001;478-484.
22. Locher R., Brandes R.P., Vetter W., Barton M. Native LDL induces proliferation of human vascular smooth muscle cells via redox-mediated activation of ERK 1/2 mitogen-activated protein kinases. Hypertension. 39:2002;645-650.
23. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., Klenk D.C. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150:1985;76-85.
24. Skalli O. A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation. J. Cell Biol. 103:1986;2787-2796.
25. Traupe T., Lang M., Goettsch W., Münter K., Morawietz H., Vetter W., Barton M. Obesity increases prostanoid-mediated vasosconstriction and vascular thromboxane receptor gene expression. J. Hypertens. 11:2002;2239-2245.
26. Mody N., Parhami F., Sarafian T.A., Demer L.L. Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic. Biol. Med. 31:2001;509-519.
27. Garrett I.R., Boyce B.F., Oreffo R.O., Bonewald L., Poser J., Mundy G.R. Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J. Clin. Invest. 85:1990;632-639.
28. Parhami F., Morrow A.D., Balucan J., Leitinger N., Watson A.D., Tintut Y., Berliner J.A., Demer L.L. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler. Thromb. Vasc. Biol. 17:1997;680-687.
29. Faggiotto A., Paoletti R. State-of-the-Art lecture. Statins and blockers of the renin-angiotensin system: vascular protection beyond their primary mode of action. Hypertension. 34:1999;987-996.